SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about updates

22 Apr 2026 Evaluate
Supriya Lifescience has informed that the US Food and Drug Administration (US FDA) conducted an inspection at the Company’s manufacturing facility located at Lote, Parshuram Industrial Area, Maharashtra, India, from 2 February 2026 to 6 February 2026. The inspection concluded with the issuance of a Form 483 containing one (1) minor observation. The Company has adequately addressed the observation and has received the Establishment Inspection Report (EIR) indicating ‘Voluntary Action Indicated (VAI)’, signifying a successful completion of the inspection. The Company remains committed to maintaining full compliance with current Good Manufacturing Practice (cGMP) requirements across all its manufacturing facilities.

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

971.90 19.45 (2.04%)
11-Jun-2026 10:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.05
Dr. Reddys Lab 1276.55
Cipla 1387.00
Zydus Lifesciences 1105.10
Lupin 2256.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×